Experience using Phenotropil in combined treatment of multiple sclerosis
D. V. Sazonov, O. V. Ryabukhina, E. V. Bulatova, N. A. Malkova, A. V. Babenko · 2010 · Atmosfera. Nervnye bolezni. No. 4, 2010, as labeled by host
What does this source report?
The report examines asthenia, mood and quality-of-life measures during adjunctive treatment. Most participants also received disease-modifying therapy.
- Population and setting
- 39 patients with relapsing or secondary-progressive multiple sclerosis
- Evidence type
- Uncontrolled human report
- Preparation
- See the original report; formulation details require verification.
- Source language
- Russian unless otherwise indicated
- Title provenance
- Title as recorded in the linked source or index. A separate original-language title has not been transcribed unless shown above.
What are the limitations?
- Uncontrolled adjunctive design; treatment contributions cannot be separated.
- The host labels the reprint as Atmosfera, No. 4, 2010; earlier reprints circulate and edition matching remains open.
Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.
Source access and review scope
Original study text in a medical-portal reprint checked; publication edition not independently matched.
Recorded source-check date: 2026-09-29. This date does not imply a completed systematic review.
Cite and trace this record
Original source: D. V. Sazonov, O. V. Ryabukhina, E. V. Bulatova, N. A. Malkova, A. V. Babenko. Experience using Phenotropil in combined treatment of multiple sclerosis Atmosfera. Nervnye bolezni. No. 4, 2010, as labeled by host 2010.
Molekul research summary: https://molekul.io/research/phenotropil-ms-2010. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entry